oncology

News in brief: Cancer drugs win unrestricted PBS listing after MOGA request; New tool calculates breast cancer risk using epigenetic factors; AMA calls for healthcare staff to receive boosters

Cancer drugs win unrestricted PBS listing after MOGA request A request from the Medical Oncology Group of Australia seeking the complete PBS derestriction of raltitrexed (Tomudex) and an unrestricted listing for liposomal doxorubicin (Caelyx ) has been approved by the Pharmaceutical Benefits Advisory Committee. At its September meeting the PBAC recommended the PBS listings for ...

Already a member?

Login to keep reading.


OR
© 2022 the limbic